BlackTreeCVE IntelligenceMedtronic · Conexus Radio Frequency Telemetry Protocol
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Patch availableThe Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement encryption. An attacker with adjacent short-range access to a target product can listen to communications, including the transmission of sensitive data.
The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement encryption. An attacker with adjacent short-range access to a target product can listen to communications, including the transmission of sensitive data.
The product transmits sensitive or security-critical data in cleartext in a communication channel that can be sniffed by unauthorized actors.
An attacker operating through an adjacent network may attempt exploitation without authentication or user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement encryption. An attacker with adjacent short-range access to a target product can listen to communications, including the transmission of sensitive data.
The product transmits sensitive or security-critical data in cleartext in a communication channel that can be sniffed by unauthorized actors.
An attacker operating through an adjacent network may attempt exploitation without authentication or user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-319: Cleartext Transmission of Sensitive Information. The product transmits sensitive or security-critical data in cleartext in a communication channel that can be sniffed by unauthorized actors.
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:NCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 26 Mar 2019 · Last source change 22 May 2025, 19:23 UTC · CWE-319 · Cleartext Transmission of Sensitive Information
Core structured fields are present and their contributing authorities are shown above.